Overview

Pharmacokinetic Study in Patients With Chronic Kidney Disease and Healthy Volunteers

Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out how chemicals in the blood of patients with chronic kidney disease affect how medications are removed from the body. The patient will take one dose of three different drugs, one on each week, for a total of three single doses. The investigators want to find out if these three different medications are affected in different ways by the chemicals in the blood of patients with kidney disease.
Phase:
Phase 1
Details
Lead Sponsor:
University of California, San Francisco
Treatments:
Eprosartan
Hydrochlorothiazide
Losartan
Propranolol